Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Limb Regeneration in Mammals Requires Blocking Two Tumor Suppressor Genes

By LabMedica International staff writers
Posted on 08 Sep 2010
Results of a study into the molecular mechanisms that control limb regeneration have revealed that while inhibition of one tumor suppressor gene enables regeneration in amphibians such as salamanders and newts, inhibition of two suppressor genes is required to initiate the regeneration process in mammals.

Investigators at Stanford University (Palo Alto, CA, USA) worked with differentiated mice muscle cells (myocytes) growing in tissue culture dishes. More...
This type of cell does not normally divide. However, in a study published in the August 6, 2010, online edition of the journal Cell Stem Cell, the investigators showed that by using siRNAs to block two tumor suppressor genes, they could induce differentiated myocytes to reenter the cell cycle and divide. One of the genes, Rb (retinoblastoma protein), was already known due to its effect on regeneration in amphibians. The other gene, Arf (alternate reading frame of the INK4a locus), had not previously been linked to regeneration in mammals, and does not exist at all in amphibians.

When the treated myocytes were transplanted into living mice they became incorporated into muscle tissue, but only if the inhibition of Rb was removed. If Rb was left blocked, the myocytes proliferated into an undifferentiated, cancer-like mass.

The investigators concluded that, "These results show that differentiation of mammalian cells is reversed by inactivation of Arf and Rb and support the hypothesis that Arf evolved at the expense of regeneration.”

Related Links:
Stanford University


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.